Companies: 48,687 Total Market Cap: 125800178376592.40

Eli Lilly and Company

NYSE: LLY
Healthcare Drug Manufacturers - General
Rank #13
Market Cap 713.09 B
Volume 12.60 M
Price 794.10
Change (%) 11.66%
Country or region United States United States

Eli Lilly and Company's latest marketcap:

713.09 B

As of May 2, 2025, Eli Lilly and Company's market capitalization has reached $713.09 B. According to our data, Eli Lilly and Company is the 13th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 713.09 B
Revenue (ttm) 49.00 B
Net Income (ttm) 11.11 B
Shares Out 897.99 M
EPS (ttm) 12.29
Forward PE 31.74
Ex-Dividend Date February 14, 2025
Earnings Date May 1, 2025
Market Cap Chart
Data Updated: May 2, 2025

Eli Lilly and Company's yearly market capitalization.

Eli Lilly and Company has seen its market value grow from $97.74 B to $831.82 B since 1998, representing a total increase of 751.04% and an annual compound growth rate (CAGR) of 8.47%.
Date Market Cap Change (%)
April 28, 2025 $831.82 B 13.5%
December 31, 2024 $732.87 B 32.44%
December 29, 2023 $553.37 B 59.19%
December 30, 2022 $347.61 B 31.56%
December 31, 2021 $264.23 B 63.6%
December 31, 2020 $161.51 B 27.99%
December 31, 2019 $126.19 B 2.94%
December 31, 2018 $122.58 B 31.81%
December 29, 2017 $93.00 B 14.54%
December 30, 2016 $81.20 B -13.04%
December 31, 2015 $93.37 B 21.55%
December 31, 2014 $76.82 B 33.69%
December 31, 2013 $57.46 B 0.39%
December 31, 2012 $57.23 B 18.95%
December 30, 2011 $48.12 B 19.08%
December 31, 2010 $40.41 B -1.52%
December 31, 2009 $41.03 B -10.38%
December 31, 2008 $45.79 B -24.4%
December 31, 2007 $60.56 B 2.72%
December 29, 2006 $58.96 B -8.34%
December 30, 2005 $64.32 B 0.16%
December 31, 2004 $64.22 B -18.68%
December 31, 2003 $78.97 B 10.71%
December 31, 2002 $71.33 B -19.21%
December 31, 2001 $88.30 B -15.83%
December 29, 2000 $104.90 B 44.66%
December 31, 1999 $72.52 B -25.8%
December 31, 1998 $97.74 B

Company Profile

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical leader dedicated to discovering, developing, and marketing innovative human healthcare solutions. Founded in 1876 and headquartered in Indianapolis, Indiana, the company operates across the United States, Europe, China, Japan, and other international markets.

Key Product Offerings

Diabetes & Obesity Treatments:

  • Basaglar, Humalog, Humulin, and insulin-based therapies
  • Jardiance, Mounjaro, and Trulicity for type 2 diabetes
  • Zepbound for obesity management

Oncology Products:

  • Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio

Other Therapeutic Areas:

  • Olumiant (rheumatoid arthritis, atopic dermatitis, COVID-19)
  • Taltz (plaque psoriasis, psoriatic arthritis)
  • Omvoh (ulcerative colitis)
  • Cymbalta (depressive disorder, chronic pain)
  • Ebglyss (severe atopic dermatitis)
  • Emgality (migraine prevention)

Strategic Collaborations

Eli Lilly partners with leading organizations to advance medical innovation, including:

  • Incyte Corporation
  • Boehringer Ingelheim Pharmaceuticals
  • F. Hoffmann-La Roche Ltd and Genentech, Inc.
  • AbCellera Biologics Inc. and Verge Genomics
  • AdvanCell (targeted cancer therapies)
  • Chugai Pharmaceutical Co., Ltd.
Frequently Asked Questions

As of May 2, 2025, Eli Lilly and Company (including the parent company, if applicable) has an estimated market capitalization of $713.09 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Eli Lilly and Company global market capitalization ranking is approximately 13 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1876
IPO Date n/a
Employees 47,000
CEO David Ricks
Sector Healthcare
Industry Drug Manufacturers - General
Address Lilly Corporate Center
Indianapolis, Indiana 46285
United States
People Also Watch
EPA-DG
141.67 0.95%
NSE-LT
39.31 0.95%
PWR
321.93 0.95%
SHA-601668
0.76 0.95%